Vitamin B6: The Coenzyme That Powers Over 100 Reactions in Your Body
If there were a competition for the most overworked vitamin cofactor in the human body, vitamin B6 would be a strong contender for the gold. Its active form, pyridoxal-5-phosphate (P5P), is a required cofactor for over 100 enzymatic reactions — involved in everything from neurotransmitter synthesis (serotonin, dopamine, GABA, and norepinephrine all require B6) to the methylation cycle to blood sugar regulation to the formation of haemoglobin in red blood cells. Given this extraordinary range of functions, it’s not surprising that B6 deficiency manifests in an extraordinarily wide range of symptoms: mood disorders, cognitive impairment, peripheral neuropathy, skin problems, immune dysfunction, and hormonal imbalances. Yet B6 deficiency is commonly overlooked, partly because standard lab reference ranges are often set too loosely and partly because the symptoms are so varied.
The neurotransmitter connection is perhaps the most immediately relevant for mental health. B6 is essential for the conversion of amino acids into neurotransmitters — specifically, it’s the cofactor for the enzymes that synthesise serotonin, dopamine, GABA, and norepinephrine. Without adequate B6, neurotransmitter production falls, and mood, anxiety levels, and cognitive function are measurably affected. Research has shown that B6 deficiency is common in depression, that B6 supplementation can improve mood in deficient individuals, and that B6 works synergistically with other B vitamins in supporting neurological function. This is why B6 is part of virtually every comprehensive B-complex and why it’s specifically implicated in the therapeutic approach to mood disorders in functional medicine.
P5P: Why This Form Matters
The distinction between standard B6 supplements (usually pyridoxine HCl) and the active form (P5P, pyridoxal-5-phosphate) is critically important for some people. P5P is the form that cells actually use — it doesn’t require conversion by the liver, which means it can be used directly. For people with genetic variations in the enzymes that convert pyridoxine to P5P (particularly the PNPO gene), or for people with liver impairment, P5P supplementation may be dramatically more effective than standard B6. For the general population with normal conversion capacity, standard pyridoxine is adequate and significantly cheaper.
The most common symptom of B6 deficiency that brings people to practitioners is peripheral neuropathy — numbness, tingling, or burning in the hands and feet. This is one of the classic signs of B6 deficiency and can occur even at doses not far above the RDA if the person has a functional B6 deficiency. People on certain medications (including some antidepressants, anticonvulsants, and the tuberculosis drug isoniazid) can develop B6 deficiency because these drugs interfere with B6 metabolism.
Dosage and Practical Considerations
The RDA for B6 is 1.3–1.7mg daily for adults, but for therapeutic applications (mood support, neurotransmitter optimisation), higher doses are commonly used. The safe upper limit is 100mg daily for long-term use, though some practitioners use higher short-term doses. For mood and neurotransmitter support, 25–50mg of pyridoxine HCl or 10–20mg of P5P daily is a common range. B6 is commonly included in B-complex formulations, and combining it with magnesium (which B6 also supports the metabolism of) is a frequent strategy for mood and neurological support.
Key Takeaways
Vitamin B6 in its active P5P form is a critical cofactor for neurotransmitter synthesis, methylation, and dozens of other enzymatic reactions. Deficiency is common and manifests as mood disorders, neuropathy, skin issues, and hormonal imbalances. For mood support and neurotransmitter function, 25–50mg pyridoxine or 10–20mg P5P daily is effective. P5P form is preferred for people with genetic variations affecting B6 metabolism. Combine with a B-complex for best results.
How GABA Works in the Nervous System
GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the mammalian central nervous system. Where glutamate promotes neuronal firing and excitation, GABA suppresses it — maintaining the balance between excitation and inhibition that allows the brain to function without constant seizure-like overactivation. GABAergic neurons make up approximately 20-30% of all neurons in the brain, and GABA receptors are present on virtually every neuronal type, making GABA the universal modulator of neural circuit activity. When GABA binds to GABA-A receptors, it opens chloride channels, hyperpolarising the neuron and making it less likely to fire. This is why GABA-promoting substances — whether pharmaceutical (benzodiazepines, barbiturates) or nutritional — tend to have calming, anxiolytic, and sometimes sedative effects.
The Gut-Brain GABA Axis
A substantial proportion of the body GABA is produced by gut bacteria, particularly Lactobacillus and Bifidobacterium species. These bacteria produce GABA via the glutamate decarboxylase pathway, and this GABA acts locally on the enteric nervous system, modulating gut motility, secretion, and pain signalling. There is bidirectional communication between gut-derived GABA and brain GABA function — the so-called gut-brain axis. Certain probiotic strains marketed as psychobiotics have been shown to increase GABA production and reduce anxiety behaviours in animal models, and preliminary human data suggests similar anxiolytic effects from specific multi-strain probiotics.
Why Oral GABA May Not Cross the Blood-Brain Barrier
A contentious area in nutritional neuroscience is whether orally consumed GABA can cross the blood-brain barrier. The evidence suggests that at typical supplemental doses (250-1000mg), systemic GABA does not meaningfully cross into the CNS. However, some studies show physiological effects from oral GABA — such as increased alpha brain wave activity on EEG and reduced cortisol — even if direct BBB penetration is minimal. Proposed mechanisms include vagal nerve activation from gut GABA receptors, or effects on peripheral GABA receptors that indirectly influence CNS function via neuroendocrine pathways.
Leave a Reply